title: [Evaluation of diagnosis and follow-up in screened children with cystic fibrosis in Normandy].
abstract: The neonatal screening programme in Normandy (France) allowed the formation of a homogenous cystic fibrosis (CF) cohort of 150 children diagnosed between 1980 and 1997. At the time of this retrospective study, 11 were deceased, out of which nine had meconium ileus (eight deaths after surgery, one at 5 years of age). Sixty children born between 1980 and 1993 in the Basse-Normandie region were followed up during a mean 80 months following similar protocols. The mean age at diagnosis was 41 days (SD = 27 d) for infants without meconium ileus. The occurrence of Pseudomonas aeruginosa (P. aeruginosa) infection and chronic colonization was studied using a monovariate followed by a multivariate analysis including the following variables: sex; meconium ileus; anthropometric data at birth and at diagnosis; pancreatic insufficiency; radiological data (Brasfield score); microbiology data at diagnosis; and genetic data. P. aeruginosa infection appeared earlier in children with pancreatic insufficiency (OR = 2.2; p < 0.05) or with radiological abnormalities (Brasfield score < 21) at diagnosis (OR = 3.9; p < 0.05). Meconium ileus (OR = 5.3; p < 0.01), pancreatic insufficiency (OR = 3.8; p < 0.01) and Brasfield score < 21 at diagnosis (OR = 5.6; p < 0.001) were prognosis factors for early chronic P. aeruginosa colonization. In CF children without meconium ileus, the major risk factor found through multivariate analysis for earlier infection and for earlier chronic colonization by P. aeruginosa was a diagnosis delay > 40 days (respectively OR = 4.6; p < 0.001 and OR = 10.4; p < 0.005). These results must be compared with the lower Brasfield score at diagnosis in infants diagnosed after 40 days of life (p < 0.01).
authors.affiliation: Services de pédiatrie A, centre hospitalier universitaire de Caen, avenue Georges-Clemenceau, 14000 Caen, France. brouard-j@chu-caen.fr
authors.forename: J
authors.initials: J
authors.lastname: Brouard
authors.forename: I
authors.initials: I
authors.lastname: Lecoq
authors.forename: J F
authors.initials: JF
authors.lastname: Viel
authors.forename: M
authors.initials: M
authors.lastname: Guillot
authors.forename: M
authors.initials: M
authors.lastname: Laurans
authors.forename: D
authors.initials: D
authors.lastname: Laroche
authors.forename: G
authors.initials: G
authors.lastname: Travert
authors.forename: J F
authors.initials: JF
authors.lastname: Duhamel
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D015331:Cohort Studies; D003550:Cystic Fibrosis / Q000150:complications / Q000175:diagnosis* / Q000473:pathology*; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D007415:Intestinal Obstruction / Q000150:complications; D008297:Male; D008403:Mass Screening; D011379:Prognosis; D011552:Pseudomonas Infections / Q000209:etiology / Q000473:pathology; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification / Q000472:pathogenicity; D012189:Retrospective Studies; D016019:Survival Analysis